State Courts

Whew! Busy, busy, busy at the statehouse, with both traditional medical marijuana bills and newfangled CBD medical marijuana bills getting lots of attention.

Medical marijuana dominates the drug policy news today, plus a legalization bill is filed in New Jersey, welfare drug testing advances in a pair of states, the Russians halt anti-drug cooperation with the US, and more.

Alaska state agencies complain that legalization will cost money (and they want some of it), Vermont cops complain the governor is soft on pot, federal prosecutors complain about reforming mandatory minimums, and more.

No legalization for Maryland this year, the ASA national conference is coming soon, Utah (!) passes a package of policing reform bills, welfare drug testing goes down in flames in Indiana, the Swiss ponder cannabis clubs, and more.

The Epilepsy Foundation comes out in support of medical marijuana, the feds delay a PTSD study, CBD bills are popping up, and a battle over local dispensary bans looms in Oregon.

California counties continue to struggle with dispensary and growing rules, Reno's mayor has a change of heart, some Oregon cities may have to change their ways, and more.

Marijuana and medical marijuana dominate the drug policy news again today, the Maryland Senate votes to ban Everclear, meth and prescription pills continue to draw legislative attention, and Schapelle Corby will soon be freed from an Indonesian jail, and more.

In a critical ruling, the Michigan Supreme Court has blocked localities from banning medical marijuana-related activities that are allowed under the state's Medical Marihuana Act.

Lots of action at the state house on medical marijuana this week, plus Arizona eases up on the rules and the Michigan Supreme Court hands down a bellwether decision in favor of patients.

The president makes some delphic comments on marijuana policy, some of his congressional critics get ready to go after him for such comment next week, Dutch cities want legal marijuana growing, the Welsh government funds a harm reduction drug testing program, and more.